PROM1 and glioblastoma: However, the percentage of the detectable CD133-positive cells in cultures isolated from glioblastoma samples and the percentage of the CD133-positive cells co-expressing the proliferation marker Ki67 inversely correlate with overall and relapse-free survival of patients [188].